Blog
Feedback
schliessen

Filtern

 

Bibliotheken

Logo der Bibliothek

Logo FID Pharmazie PubPharm Discovery System Universitätsbibliothek Braunschweig Institut für Informationssysteme

Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19)

Recent evidence supports the use of an early, short course of glucocorticoids in patients with COVID-19 who require mechanical ventilation or oxygen support. As the number of coronavirus disease 2019 (COVID-19) cases continues to increase, the number of pregnant women with the disease is very likely to increase as well. Because pregnant women are at increased risk for hospitalization, intensive care unit admission, and mechanical ventilation support, obstetricians will be facing the dilemma of initiating maternal corticosteroid therapy while weighing its potential adverse effects on the fetus (or neonate if the patient is postpartum and breastfeeding). Our objective is to summarize the current evidence supporting steroid therapy in the management of patients with acute respiratory distress syndrome and COVID-19 and to elaborate on key modifications for the pregnant patient

Year of Publication: 2020
Contained in: Obstetrics and gynecology Vol. 136, No. 4 (2020), p. 823-826
All journal articles: Search for all articles in this journal
Language: English
Contributors: Saad, Antonio F | Author
Chappell, Lucy
Saade, George R
Pacheco, Luis D
Full text access:
Electronic availability is being checked...
Links: Full Text (dx.doi.org)
Keywords: Glucocorticoids
Journal Article
Additional Keywords: *Coronavirus Infections
*Glucocorticoids
*Pandemics
*Pneumonia, Viral
*Pregnancy Complications, Infectious
Betacoronavirus
Critical Care
Drug Monitoring
Female
Fetal Organ Maturity
Humans
Infant, Newborn
Medication Therapy Management
Oxygen Inhalation Therapy
Pregnancy
Respiration, Artificial
Risk Assessment
ISSN: 1873-233X
Note: Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Notes: Date Completed 05.10.2020
Date Revised 05.10.2020
published: Print
Citation Status MEDLINE
Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
PMID:
    32769659
Physical Description: Online-Ressource
ID (e.g. DOI, URN): 10.1097/AOG.0000000000004103
more publication details ...

Associated Publications

  • Associated records are being queried...
more (+)
Internes Format
LEADER 03358nma a2200625 c 4500
001 NLM314377727
003 DE-601
005 20201006213702.0
007 cr uuu---uuuuu
008 200810s2020 000 0 eng d
024 7 |a 10.1097/AOG.0000000000004103  |2 doi 
028 5 2 |a pubmed20n1422.xml 
035 |a (DE-599)NLM32769659 
040 |b ger  |c GBVCP 
041 0 |a eng 
100 1 |a Saad, Antonio F 
245 1 0 |a Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19)  |h Elektronische Ressource 
300 |a Online-Ressource 
500 |a Date Completed 05.10.2020 
500 |a Date Revised 05.10.2020 
500 |a published: Print 
500 |a Citation Status MEDLINE 
500 |a Copyright: From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine 
520 |a Recent evidence supports the use of an early, short course of glucocorticoids in patients with COVID-19 who require mechanical ventilation or oxygen support. As the number of coronavirus disease 2019 (COVID-19) cases continues to increase, the number of pregnant women with the disease is very likely to increase as well. Because pregnant women are at increased risk for hospitalization, intensive care unit admission, and mechanical ventilation support, obstetricians will be facing the dilemma of initiating maternal corticosteroid therapy while weighing its potential adverse effects on the fetus (or neonate if the patient is postpartum and breastfeeding). Our objective is to summarize the current evidence supporting steroid therapy in the management of patients with acute respiratory distress syndrome and COVID-19 and to elaborate on key modifications for the pregnant patient 
611 2 7 |a Journal Article  |2 gnd 
653 2 |a Betacoronavirus  |6 D000073640  |a isolation & purification  |6 Q000302 
653 2 |a *Coronavirus Infections  |6 D018352  |a epidemiology  |6 Q000453  |a therapy  |6 Q000628 
653 2 |a Critical Care  |6 D003422  |a *methods  |6 Q000379 
653 2 |a Drug Monitoring  |6 D016903  |a methods  |6 Q000379 
653 2 |a Female  |6 D005260 
653 2 |a Fetal Organ Maturity  |6 D005325  |a drug effects  |6 Q000187 
653 2 |a *Glucocorticoids  |6 D005938  |a classification  |6 Q000145  |a pharmacology  |6 Q000494 
653 2 |a Humans  |6 D006801 
653 2 |a Infant, Newborn  |6 D007231 
653 2 |a Medication Therapy Management  |6 D054539  |a *standards  |6 Q000592 
653 2 |a Oxygen Inhalation Therapy  |6 D010102  |a methods  |6 Q000379 
653 2 |a *Pandemics  |6 D058873 
653 2 |a *Pneumonia, Viral  |6 D011024  |a epidemiology  |6 Q000453  |a therapy  |6 Q000628 
653 2 |a Pregnancy  |6 D011247 
653 2 |a *Pregnancy Complications, Infectious  |6 D011251  |a epidemiology  |6 Q000453  |a therapy  |6 Q000628  |a virology  |6 Q000821 
653 2 |a Respiration, Artificial  |6 D012121  |a methods  |6 Q000379 
653 2 |a Risk Assessment  |6 D018570 
655 7 |a Glucocorticoids  |2 gnd 
689 0 0 |A f  |a Journal Article 
689 0 |5 DE-601 
689 2 0 |a Glucocorticoids 
689 2 |5 DE-601 
700 1 |a Chappell, Lucy 
700 1 |a Saade, George R 
700 1 |a Pacheco, Luis D 
773 0 8 |i in  |t Obstetrics and gynecology  |g Vol. 136, No. 4 (2020), p. 823-826  |q 136:4<823-826  |w (DE-601)NLM000021539  |x 1873-233X 
856 4 1 |u http://dx.doi.org/10.1097/AOG.0000000000004103  |3 Volltext 
912 |a GBV_NLM 
951 |a AR 
952 |d 136  |j 2020  |e 4  |b 25  |c 10  |h 823-826